Highlights

Pr Stephen Stilgenbauer: Venetoclax in high-risk refractory CLL Pr Stephen Ansell: Nivolumab and Refractory Classical Hodgkin Lymphoma EASD 2015 - An SGLT-2 antagonist reduces mortality in type 2 diabetes ESC 2015 - New treatment for resistant hypertension GMFH 2015 - Probiotics, gut microbiota and health GMFH 2015 - Gut microbiota, inflammation and immunity EB 2014 - The global challenge of high quality proteins intake

Pr Stephen Stilgenbauer: Venetoclax in high-risk refractory CLL

Today we’ll be devoting our program to the treatment of high-risk relapsed/refractory Chronic Lymphocytic Leukemia At the 2015 American Societu of Hematology meeting, which took place in Orl...

Pr Stephen Ansell: Nivolumab and Refractory Classical Hodgkin Lymphoma

Today we’ll be devoting our program to the treatment of the refractory Hodgkin Lymphoma At the 2015 American Society of Hematology meeting, which took place in Orlando, we interviewed Pr St...

EASD 2015 - An SGLT-2 antagonist reduces mortality in type 2 diabetes

Empagliflozine, an SGLT-2 antagonist, on top of the classic treatment of type 2 diabetes patients at high risk is associated with a reduction in the HbA1c level and the cardiovascular and total mortality....

ESC 2015 - New treatment for resistant hypertension

Spironolactone 25-50 mg daily on top of antihypertensive tritherapy seems to be the most effective drug treatment for resistant hypertension. This low dose is well tolerated if the renal function and serum potassium leves are monitored...

GMFH 2015 - Probiotics, gut microbiota and health

The use of probiotics to benefit the gut microbiota was viewed as promising at the Gut Microbiota For Health 2015 conference. The prospects for using probiotics now look more promising because of an ISAPP consensus on how to validate the different be...

GMFH 2015 - Gut microbiota, inflammation and immunity

New data in what scientists consider to be « a new organ », the gut microbiota, were reported during the 2015 World Summit Gut Microbiota for Health. The experts who attended this meeting heard about the last discoveries on the...

EB 2014 - The global challenge of high quality proteins intake

Protein intake isn’t as simple as looking at protein and grams per day. The source really does matter in regards to quality according to the experts attending the 2nd World Yoghurt Summit. Every year, the Yoghurt in Nutrition Initiative for a ...

RSS
Twitter
Facebook
Timeline
Partnership

ASCO 2014 - Advances in Breast Cancer at the 2014 ASCO meeting

ASCO 2014 - Advances in Breast Cancer at the 2014 ASCO meeting
Url
ASCO 2014 - Advances in Breast Cancer at the 2014 ASCO meeting

Best of Science in Nutrition 2013: Yogurt for a healthier diet (EB & IUNS 2013)

Best of Science in Nutrition 2013: Yogurt for a healthier diet (EB & IUNS 2013)
Url
Best of Science in Nutrition 2013: Yogurt for a healthier diet (EB & IUNS 2013)
with
Danone Institute International